目錄:杭州斯達(dá)特生物科技有限公司>>抗體/抗原>>病理/IHC抗體>> S0B2183CD30 Recombinant Rabbit mAb (SDT-216-2)
參考價(jià) | ¥ 600 |
參考價(jià) | ¥ 600 |
更新時(shí)間:2025-06-12 08:52:04瀏覽次數(shù):8評(píng)價(jià)
聯(lián)系我們時(shí)請(qǐng)說明是化工儀器網(wǎng)上看到的信息,謝謝!
CD30 is a transmembrane protein from the tumour necrosis factor receptor superfamily. It is expressed on a small subset of activated T and B lymphocytes, and various lymphoid neoplasms. CD30 is a particularly treatment target because its levels are high in tumours but low in healthy tissues. Several therapeutic strategies targeting CD30 have been developed, including monoclonal antibodies, conjugated antibodies (combination of brentuximab vedotin with chemotherapy or immunotherapy), bispecific antibodies and cell and gene therapies, such as anti-CD30 CAR-T cells in particular [PMID: 37170397].
(空格分隔,最多3個(gè),單個(gè)標(biāo)簽最多10個(gè)字符)